HEp-2 staining pattern . | Antigen(s) . | Disease associations . |
---|---|---|
Nuclear staining . | ||
Homogeneous nuclear/nucleolar | dsDNA, histones, topoisomerase 1, Ku | SLE |
Homogeneous nuclear (nucleoli negative) | Histone | SLE, drug-induced SLE |
Nuclear membrane | Lamins A, B, C | Autoimmune liver disease anti-phospholipid syndrome leucocystoclastic vasculitis |
Nuclear pore (punctate staining) | gp210 pore protein, lamin B receptor | Primary biliary cirrhosis |
Peripheral nuclear | dsDNA | SLE |
Nuclear matrix (coarse speckles) | hn-RNP | SLE |
Coarse speckled | U1-RNP, Sm, Ki | SLE, MCTD |
Fine speckled | Ro, La, Mi-2 | SLE, Sjögren’s, dermatomysositis |
Granular nuclear staining | Topoisomerase 1 (Scl-70) | Systemic sclerosis |
Coarse and fine speckles | PCNA | SLE |
Centromere (condensed in metaphase plates) | CENP-A, -B, -C | CREST, limited scleroderma |
Nuclear dots (2–6) Nsp-1 | p80 coilin | PBC |
Nuclear dots (6–10, up to 30): pseudo-centromere | Sp100 | PBC (AMA negative) |
Homogeneous nucleolar | Pm-Scl, Ku, nucleolin | Polymyositis–scleroderma overlap |
Clumpy nucleolar | Fibrillarin | Systemic sclerosis |
Speckled nucleolar | RNA Pol 1 | Systemic sclerosis |
Nucleolar dots | Nor-90 (nucleolar organizer region) | Scleroderma |
Centriole | Centriole | Non-specific (CTDs, post-infective) |
Nuclear mitotic spindle apparatus (NuMa, MSA-1) | NuMA protein | Non-specific CTD |
Mitotic spindle apparatus-2 (MSA-2) | Mid-body | Systemic sclerosis, Raynaud’s mid-body pattern |
Mitotic spindle apparatus -3 (MSA-3) | CENP-F | Respiratory tract tumours |
Cytoplasmic | ||
Mitochondria (large granule staining) | Multiple antigens (M1–M9) | PBC, autoimmune liver disease |
Ribosomes | Ribosomal P proteins | SLE |
Irregular granular staining | Lysosomes, peroxisomes | Non-specific |
Fine speckled | Jo-1, other tRNA synthetases | Polymyositis |
Golgi body | Giantin (50%) golgins 245, 160, 95, 97 | SLE, Sjögren’s, other CTDs, chronic CMV |
Actin filaments | Actin | Autoimmune hepatitis |
Vimentin | Vimentin | SLE, other CTDs |
Cytokeratin | Cytokeratin 18 | RhA |
HEp-2 staining pattern . | Antigen(s) . | Disease associations . |
---|---|---|
Nuclear staining . | ||
Homogeneous nuclear/nucleolar | dsDNA, histones, topoisomerase 1, Ku | SLE |
Homogeneous nuclear (nucleoli negative) | Histone | SLE, drug-induced SLE |
Nuclear membrane | Lamins A, B, C | Autoimmune liver disease anti-phospholipid syndrome leucocystoclastic vasculitis |
Nuclear pore (punctate staining) | gp210 pore protein, lamin B receptor | Primary biliary cirrhosis |
Peripheral nuclear | dsDNA | SLE |
Nuclear matrix (coarse speckles) | hn-RNP | SLE |
Coarse speckled | U1-RNP, Sm, Ki | SLE, MCTD |
Fine speckled | Ro, La, Mi-2 | SLE, Sjögren’s, dermatomysositis |
Granular nuclear staining | Topoisomerase 1 (Scl-70) | Systemic sclerosis |
Coarse and fine speckles | PCNA | SLE |
Centromere (condensed in metaphase plates) | CENP-A, -B, -C | CREST, limited scleroderma |
Nuclear dots (2–6) Nsp-1 | p80 coilin | PBC |
Nuclear dots (6–10, up to 30): pseudo-centromere | Sp100 | PBC (AMA negative) |
Homogeneous nucleolar | Pm-Scl, Ku, nucleolin | Polymyositis–scleroderma overlap |
Clumpy nucleolar | Fibrillarin | Systemic sclerosis |
Speckled nucleolar | RNA Pol 1 | Systemic sclerosis |
Nucleolar dots | Nor-90 (nucleolar organizer region) | Scleroderma |
Centriole | Centriole | Non-specific (CTDs, post-infective) |
Nuclear mitotic spindle apparatus (NuMa, MSA-1) | NuMA protein | Non-specific CTD |
Mitotic spindle apparatus-2 (MSA-2) | Mid-body | Systemic sclerosis, Raynaud’s mid-body pattern |
Mitotic spindle apparatus -3 (MSA-3) | CENP-F | Respiratory tract tumours |
Cytoplasmic | ||
Mitochondria (large granule staining) | Multiple antigens (M1–M9) | PBC, autoimmune liver disease |
Ribosomes | Ribosomal P proteins | SLE |
Irregular granular staining | Lysosomes, peroxisomes | Non-specific |
Fine speckled | Jo-1, other tRNA synthetases | Polymyositis |
Golgi body | Giantin (50%) golgins 245, 160, 95, 97 | SLE, Sjögren’s, other CTDs, chronic CMV |
Actin filaments | Actin | Autoimmune hepatitis |
Vimentin | Vimentin | SLE, other CTDs |
Cytokeratin | Cytokeratin 18 | RhA |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.